- Report
- January 2023
- 97 Pages
Europe
From €1331EUR$1,500USD£1,146GBP
- Clinical Trials
- July 2024
- 458 Pages
Global
From €3062EUR$3,450USD£2,636GBP
- Report
- June 2024
- 80 Pages
Global
From €3102EUR$3,495USD£2,670GBP
- Report
- May 2024
- 67 Pages
Global
From €3102EUR$3,495USD£2,670GBP
- Report
- December 2023
- 78 Pages
Global
From €3102EUR$3,495USD£2,670GBP
- Report
- November 2023
- 1203 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- January 2023
- 1469 Pages
Global
From €4438EUR$5,000USD£3,820GBP
- Report
- November 2022
- 244 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- November 2022
- 624 Pages
Global
From €2219EUR$2,500USD£1,910GBP
- Report
- June 2022
- 62 Pages
Global
From €3102EUR$3,495USD£2,670GBP
- Report
- November 2021
- 108 Pages
Global
From €13310EUR$14,995USD£11,455GBP
- Report
- November 2018
- 30 Pages
Global
From €3546EUR$3,995USD£3,052GBP
- Report
- February 2024
- 140 Pages
Global
From €4411EUR$4,969USD£3,796GBP
- Report
- February 2024
- 180 Pages
Global
From €4411EUR$4,969USD£3,796GBP
- Report
- February 2024
- 160 Pages
Global
From €4411EUR$4,969USD£3,796GBP
- Report
- February 2024
- 180 Pages
Global
From €4411EUR$4,969USD£3,796GBP
- Report
- April 2023
- 147 Pages
Global
From €4393EUR$4,949USD£3,781GBP
- Report
- April 2023
- 160 Pages
Global
From €4393EUR$4,949USD£3,781GBP
- Report
- April 2023
- 147 Pages
Global
From €4393EUR$4,949USD£3,781GBP
- Report
- April 2023
- 147 Pages
Global
From €4393EUR$4,949USD£3,781GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more